| Date | Title | Description |
| 11.11.2025 | SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine | BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific disc... |
| 15.09.2025 | The Scientist Unveils the 2025 Top Innovations Award Winners | The Scientist Top 10 Innovations of 2025
Fourteen breakthrough technologies are recognized across biotechnology, healthcare, lab tools, and startup innovations.
WILMINGTON, Del., Sept. 15, 2025 /PRNewswire-PRWeb/ -- The Scientist proudly an... |
| 23.04.2025 | Revolutionizing Cancer Care: The Promise of ctDNA Monitoring in Asia | In the fight against cancer, time is often the enemy. Early detection and timely intervention can mean the difference between life and death. As cancer rates soar in Asia, innovative solutions are emerging to combat this growing crisis. A r... |
| 22.04.2025 | GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY | HO CHI MINH CITY, April 22, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, h... |
| 13.09.2024 | These Female Founders And CEOs Raised The Biggest Rounds In 2024 | 6 Shares Email Facebook Twitter LinkedIn
When measuring funding to startups with female founders and CEOs, the perennial takeaway is that women remain underrepresented. Last year, for instance, just 3% of U.S. funding went to startups with ... |
| 25.07.2024 | Element Biosciences: A New Era in DNA Sequencing**
** | ** Element Biosciences is on a mission. The San Diego-based company is reshaping the landscape of DNA sequencing and multi-omics technology. With a recent infusion of over $277 million in Series D funding, Element is poised to democratize a... |
| 23.07.2024 | Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools | Element Biosciences, a developer of pioneering technologies to empower science, announced over $277 million in Series D funding to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for year... |
| 11.07.2024 | Element Biosciences Raises Over $277M in Series D Funding | Element Biosciences, a San Diego, CA-based developer of technologies to empower science, raised over $277M in Series D funding.
The round, which brought the total amount to over $680M, was led by Wellington Management with participation fro... |
| 14.05.2024 | Element Biosciences Announces Record Sequencer Installation Growth Ahead of Participation in Investor Conferences | SAN DIEGO, May 14, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced record growth in installations of its AVITI™ System ahead of its participation in upcoming investor ... |
| 31.01.2024 | Source Genomics expands sequencing portfolio with first UK commercial service on the Element Biosciences AVITI™ System | Cambridge, UK - Source Genomics, a part of the Source BioScience Group, announces their genomic laboratory expansion by adding an Element Biosciences AVITI™ System to its fleet of sequencers.
As the demand for genomic sequencing increases i... |
| 17.04.2023 | Phase Genomics Collaborates with Element Biosciences to Optimize Cytogenomics for Liquid and Solid Tumor Samples | The Element AVITI System rapidly delivers high-quality, cost-effective data to accelerate cytogenomic research on Phase Genomics’ OncoTerra Platform
Phase Genomics, a leading developer of cutting-edge genomic solutions, and Element Bioscien... |
| 07.02.2023 | Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future | MäNNEDORF, SWITZERLAND, February 7, 2023 /EINPresswire.com/ -- Tecan has partnered with Singular Genomics to use the turnkey MagicPrep™ NGS system* to create sequencing-ready libraries for the G4™ Sequencing Platform. The agreement will bri... |
| 24.03.2022 | Element Launches AVITI Benchtop Sequencer | Photo courtesy of Element Biosciences The new Element AVITI System sequencer offers high-quality data at a price tag of $289,000.
In a virtual presentation held March 14, Element Biosciences announced the commercial launch of its AVITI benc... |
| 14.03.2022 | Armed with heaps of cash and a veteran team, an upstart looks to disrupt DNA sequencing | SAN DIEGO — After quietly raising hundreds of millions of dollars and building a team stacked with genomics pros, Element Biosciences announced on Monday the commercial launch of its new DNA sequencer — and with it, plans to rival industry ... |
| 01.07.2021 | Element Biosciences Raises $276M in Series C Financing | Element Biosciences, a San Diego, CA-based developer of a DNA sequencing platform, closed a $276m Series C financing.
Backers included new investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (M... |
| 30.06.2021 | Can J.Crew make a comeback? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Why marketers are adopting a scientific approach From Optimizely
It was not too long... |
| 30.06.2021 | Can J.Crew make a comeback? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
It was not too long ago that its clothing was plastered across the pages of fashion and political... |
| 29.06.2021 | Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics | |
| 29.06.2021 | DNA sequencing upstart Element Biosciences raises $276M ahead of its first product launch | Emerging DNA sequencer developer Element Biosciences has more than doubled its venture capital war chest, with the goal of offering low-cost, modular hardware in a market dominated by a small number of players.
Though details on the system ... |
| 29.06.2021 | Element Biosciences : Closes $276 Million Series C Financing to Democratize Access to Genomics | SAN DIEGO, June 29, 2021 /PRNewswire/ -- Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos Capital,... |
| 29.06.2021 | Element Biosciences obtains a $276M Series C Round to develop their innovative DNA sequencing platform | - |
| 29.06.2021 | Element Biosciences, Inc. announced that it has received $276 million in funding from a group of investors | Element Biosciences, Inc. announced that it has received $276,000,000 in its series C round of funding on June 29, 2021. The transaction includes participation from other new investors, Janus Henderson Group plc (NYSE:JHG), Logos Capital Ma... |
| 29.06.2021 | DNA sequencing upstart Element Biosciences raises $276M ahead of its first product launch | Emerging DNA sequencer developer Element Biosciences has more than doubled its venture capital war chest, with the goal of offering low-cost, modular hardware in a market dominated by a small number of players.
The San Diego-based company’s... |
| 25.02.2021 | Biotech and healthtech firm Foresite Capital raises $969M new fund | The firm, which now has over $4 billion in assets under management, invests across all stages
The biotech space has been growing in the last few years: according to Pitchbook, the space was on track to see more than $20 billion invested in ... |
| 10.01.2020 |
Element Biosciences Gets $80M For DNA Sequencing
| San Diego-based Element Biosciences, which is developing DNA sequencing technology, says it has raised $80M in a Series B funding round. The new funding came from Fidelity Management & Research Company and JS Capital LLC, along with For... |
| 09.01.2020 | Element Biosciences has raised $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform | - |
| 18.06.2019 | Element Biosciences Raises $15M in Series A Financing | Element Biosciences, Inc., a San Diego, Calif.-based company focused on the development of genetic analysis tools, secured $15m in Series A funding.
The round was led by Foresite Capital and Venrock.
The company intends to use the funds for... |
| 18.06.2019 | Top tech startup news for today, Tuesday, June 18, 2019 | Below are some of the top tech startup news for today, Tuesday, June 18, 2019.
Orbit Fab becomes the first startup to demonstrate satellite refueling technology on ISS. Orbit Fab, a two-year old startup that dubbed itself as “Gas stations ... |
| - | Element Biosciences | “Our new benchtop sequencing platform - AVITI™ - allows scientists to transform their research from inquiry to insight to create tangible impact for the real world.” |
| - | StartUPDATES: New developments from healthcare startups | Element Biosciences, developer of a new and disruptive DNA sequencing platform, recently announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long... |
| - | StartUPDATES: New developments for healthcare startups | Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced the commercial launch of the Element AVITI System, a benchtop sequencer offering an unrivaled combination of performance, cost, and flexibi... |
